Latest Delhi’s Intermediate Reference Laboratory News & Updates

Study Shows Shorter TB Treatment Regimens More Cost-Effective

By

New Delhi, Feb 12 (IANS) Shorter, six‑month and all‑oral treatment regimens for multidrug‑resistant and rifampicin‑resistant tuberculosis (MDR/RR‑TB) are cost‑effective and deliver better health outcomes than longer regimens, an ICMR study said on Thursday.With shorter regimen, “for each additional Quality Adjusted Life Year (QALY) gained, the health system spends Rs 379 less per patient compared to the standard regimen, indicating better health outcomes at lower costs,” said the s…